Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Valproic acid sodium salt (Sodium Valproate) 是一种HDAC 抑制剂,可抑制HDAC1的活性,诱导HDAC2的降解。它激活Notch1信号并抑制小细胞肺癌细胞的增殖。它可研究癫痫、偏头痛和双相情感障碍等。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
500 mg | ¥ 250 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 440 | 现货 |
产品描述 | Valproic acid sodium salt (Sodium Valproate) is the sodium salt form of valproic acid with anti-epileptic activity. Valproic acid sodium salt is converted into its active form, valproate ion, in blood. Although the mechanism of action remains to be elucidated, Valproic acid sodium salt increases concentrations of gamma-aminobutyric acid (GABA) in the brain, probably due to inhibition of the enzymes responsible for the catabolism of GABA. This potentiates the synaptic actions of GABA. Valproic acid sodium salt may also affect potassium channels, thereby creating a direct membrane-stabilizing effect. |
靶点活性 | HDAC1:0.4 mM |
体外活性 | 在MT-450大鼠乳腺癌模型中,Valproic acid对原发肿瘤的生长具有延迟作用. |
体内活性 | 在培养的细胞中,Valproic acid与组蛋白去乙酰化酶抑制剂曲古抑菌素A一样可引起组蛋白去乙酰化。Valproic acid,如曲古抑菌素 A,也激活不同的外源性和内源性启动子的转录。在脊椎动物的胚胎中,Valproic acid和曲古抑菌素A的致畸作用非常相似,却不激活转录。 通过不同的途径Valproic acid可直接抑制组蛋白脱乙酰基酶,对HDAC1的IC50为0.4 mM。在F9和P19畸胎瘤细胞中,Valproic acid抑制细胞增殖或存活,表现为[3H]胸苷渗入下降。Valproic acid还促进啮齿动物肝脏过氧化物酶体增殖。在表达糖皮质激素受体的DNA结合域和PPARδ的配体结合结构域,以及GR控制的报告基因融合的细胞中,Valproic acid(1 mM)抑制与N-COR,TR或PPARδ融合的Gal4释放。Valproic acid诱导乙酰化组蛋白积累的减少并抑制HDAC活性。Valproic acid诱导特定类型分化,标志是增殖减少,形态改变,AP-2的转录因子累积和标志物基因表达,AP-2是神经元或神经嵴细胞样分化的F9畸胎瘤细胞的潜在标记物。 |
激酶实验 | The activity of caspase-3, -8 and -9 is assessed using the caspase-3, -8 and -9 colorimetric assay kits, respectively. In brief, 1×106?cells in a 60-mm culture dish are incubated with 10 mM Valproic acid for 24 h. The cells are then washed in PBS and suspended in 5 volumes of lysis buffer provided with the kit. Protein concentrations are determined using the Bradford method. Supernatants containing 50 μg total protein are used to determine caspase-3, -8 and -9 activities. The supernatants are added to each well in 96-well microtiter plates with DEVD-pNA, IETD-pNA or LEHD-pNA as caspase-3, -8 and -9 substrates and the plates are incubated at 37°C for 1 h. The optical density of each well is measured at 405 nm using a microplate reader. The activity of caspase-3, -8 and -9 is expressed in arbitrary absorbance units. |
细胞实验 | Valproic acid is dissolved in DMSO. In brief, 5×105?cells are seeded in 96-well microtiter plates for MTT assays. After exposure to the designated doses of Valproic acid for the indicated times, MTT solution [20 mL: 2 mg/mL in phosphate-buffered saline (PBS)] is added to each well of the 96-well plates. The plates are additionally incubated for 3 h at 37°C. Medium is withdrawn from the plates by pipetting and 200 mL DMSO is added to each well to solubilize the formazan crystals. The optical density is measured at 570 nm using a microplate reader. |
别名 | 丙戊酸钠, Sodium Valproate |
分子量 | 166.2 |
分子式 | C8H15NaO2 |
CAS No. | 1069-66-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 8.3 mg/mL (50 mM)
H2O: 16.6 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO / H2O | 1 mM | 6.0168 mL | 30.0842 mL | 60.1685 mL | 150.4212 mL |
5 mM | 1.2034 mL | 6.0168 mL | 12.0337 mL | 30.0842 mL | |
10 mM | 0.6017 mL | 3.0084 mL | 6.0168 mL | 15.0421 mL | |
20 mM | 0.3008 mL | 1.5042 mL | 3.0084 mL | 7.5211 mL | |
50 mM | 0.1203 mL | 0.6017 mL | 1.2034 mL | 3.0084 mL | |
H2O | 100 mM | 0.0602 mL | 0.3008 mL | 0.6017 mL | 1.5042 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Valproic acid sodium salt 1069-66-5 Autophagy Chromatin/Epigenetic DNA Damage/DNA Repair Membrane transporter/Ion channel Microbiology/Virology Neuroscience Proteases/Proteasome Stem Cells Mitophagy Gamma-secretase HIV Protease GABA Receptor HDAC bipolar disorder 丙戊酸钠 Valproic acid anticonvulsant SCLC hepatic fat accumulation degradation Histone deacetylases HIV Mitochondrial Autophagy Notch inhibit Apoptosis Sodium Valproate anticancer Endogenous Metabolite headaches epilepsy small cell lung cancer Inhibitor Human immunodeficiency virus proteasomal Notch1 Valproic acid sodium migraine inhibitor